Progress on an Implantable Artificial Kidney Reported at ASN
The Kidney Project, led by Shuvo Roy, PhD and nephrologist William H. Fissell, MD, is developing a two-part, deck-of-cards sized implantable bioartificial kidney to replace dialysis. A hemofilter will remove toxins. A bioreactor containing human kidney cells will control fluid volume and blood pressure, adjust salts, and make hormones. At ASN Kidney Week 2019, the project announced that a prototype bioreactor was successfully placed in large animals with no immune reaction or blood clots—and no immunosuppression needed. The system now awaits FDA approval to do a clinical safety trial.
Read the full article » | Posted 11-16-2019
Related Articles
- Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
- FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
- Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
- Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026

